Cover Image
市場調查報告書

全球感染疾病診斷檢驗市場

Infectious Disease Diagnostic Testing: World Market Analysis of TB, Flu, HIV, Hepatitis, Strep A, Malaria, HPV, Blood Screening, STDs, ID/AST, HAI, Rapids and Other Test Products

出版商 Kalorama Information 商品編碼 96362
出版日期 內容資訊 英文 327 Pages
訂單完成後即時交付
價格
Back to Top
全球感染疾病診斷檢驗市場 Infectious Disease Diagnostic Testing: World Market Analysis of TB, Flu, HIV, Hepatitis, Strep A, Malaria, HPV, Blood Screening, STDs, ID/AST, HAI, Rapids and Other Test Products
出版日期: 2018年02月26日 內容資訊: 英文 327 Pages
簡介

本報告提供全球感染疾病診斷檢驗市場相關調查分析,提供市場規模,2025年為止的預測,企業簡介,趨勢的評估,檢驗概要,各檢驗技術,POC分別分析等相關的系統性資訊。

摘要整理

簡介

全球感染疾病市場分析

  • 全球感染疾病診斷市場
  • 全球感染疾病市場:各國
    • 美國
    • 加拿大
    • 德國
    • 西班牙
    • 法國
    • 義大利
    • 英國
    • 其他EU
    • 東歐
    • 日本
    • 澳洲
    • 新加坡
    • 中國
    • 馬來西亞
    • 土耳其
    • 沙烏地阿拉伯
    • 南非
    • 俄羅斯
    • 印度
    • 巴西
    • 台灣
    • 韓國
    • 墨西哥
    • 智利
    • 哥倫比亞
    • 其他南美
    • 其他地區

市場企業

  • Abbott Diagnostics
  • Beckman Coulter, Inc. / Danaher
  • Becton, Dickinson and Company (BD)
  • bioMerieux Inc.
  • Bio-Rad Laboratories, Inc.
  • Cepheid / Danaher
  • Danaher Corporation
  • Grifols
  • Hologic, Inc.
  • InSilixa, Inc
  • Meridian BioScience, Inc
  • Ortho Clinical Diagnostics
  • PerkinElmer, Inc. (PE)
  • QIAGEN N.V.
  • Quidel Corporation
  • Roche Diagnostics
  • Siemens Healthineers
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech PLC
  • WAMA Diagnostica
  • Wave 80 Biosciences
  • Xagenic

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: KLI15607955

Nearly a third of the revenues earned from clinical testing products are earned from products that detect infectious diseases

Despite this enormous size, the market remains dynamic. It's also a global market: the entire world prioritizes infectious disease in its healthcare provision. Indeed, the demand to detect and counter infectious disease threats has helped launch new technologies such as molecular systems and point of care, PCR-alternative molecular amplification methods, next-generation sequencing (NGS), microarrays and other technologies. Infectious disease testing offers a mix of some mature segments with rapid spikes in market growth in the infectious disease test market can occur with the emergence of new disease threats or acceptance of new routine screening procedures.

Key segments include TB, Flu, HIV, Hepatitis, Strep A, Malaria, HPV, Blood Screening, STDs, ID/AST, Rapids, HAI and Other Test Products

Kalorama Information's new report, The World Market for Infectious Disease Diagnostics: World Market Analysis, is designed to provide a total picture of the market for products that test for infectious diseases to aid clinical decisions. Readers will benefit from a complete world country analysis, with major country markets defined for each segment, a total of 348 market tables provided. The enhanced segmentation allows for better business planning and market opportunity sizing.

25-Country and Region Market Analysis with over 340 Tables

Managed care in the United States and other developed countries demands quicker and more specific test results for infectious diseases. Rapid, near-patient testing can be used to rationalize antimicrobial usage and reduce repeat physician office visits. However, cost improvements are needed to widen the role of test products used in POC and POL settings as decentralized testing is disproportionately affected by cuts to reimbursements and pricing pressure on laboratory services and diagnostic procedures.

‘Infectious Disease Diagnostic Testing: World Market Analysis’ covers 30 areas of infectious diseases. Diseases and technology categories covered in this report include:

  • Blood Screening Immunoassay
  • Blood Screening NAT
  • Influenza Tests
  • Strep A Test
  • RSV Testing
  • Malaria Tests
  • Dengue Testing
  • HIV Tests - Laboratories
  • HIV Tests - POC
  • Hepatitis Testing, Lab-Based
  • Hepatitis Testing, POC
  • STD Testing
  • HPV Testing
  • TORCH Testing
  • TB Labs
  • TB POC
  • ID/AST Market, Auto
  • ID/AST, Manual
  • Blood Culture
  • Chromogenic Media
  • Rapid Micro
  • Sepsis
  • MRSA
  • C. diff
  • VRE
  • Other HAI
  • Parasitology
  • Mycology
  • Emerging Infectious Disease Tests
  • Home OTC
  • Other

Advancements in instrument automated analysis and microfluidics have allowed for the proliferation of infectious disease testing across settings and institutions - from traditional sites such as reference labs through physician office laboratories (POLs) and mobile clinics in the developing world. For each of these product segments, the report provides a market size and forecast 2017-2025 for the following countries:

  • United States
  • Canada
  • Germany
  • France
  • Spain
  • UK
  • Italy
  • Other Europe
  • Australia
  • Japan
  • China
  • Eastern Europe
  • South Africa
  • Indonesia
  • Malaysia
  • Singapore
  • India
  • Saudi Arabia
  • Turkey
  • Russia
  • Taiwan
  • South Korea
  • Brazil
  • Chile
  • Columbia
  • Other LATAM
  • ROW

In addition, the report provides:

  • Global Market Sizing
  • Forecasts to 2025
  • Company Profiles of Infectious Disease Testing providers
  • Assessment of Trends
  • Overview of Types of Testing
  • Breakout by testing technology (molecular, immunoassay) for Hepatitis and HIV
  • Breakout by POC vs. lab-test by technology (Hepatitis, HIV, TB, other)

Increased funding for infectious disease diagnostics from international governmental, non-governmental and non-profit health organizations is assisting in the development of a new generation of sophisticated test platforms designed to meet the needs of testing in low-resource environments (electricity, water, refrigeration, other environmental control, and personnel).

Payers in the industrialized world are being encouraged and have been receptive to increased coverage of infectious disease testing and screening. While preventive testing services are traditionally associated with “lifestyle” or non-communicable diseases, infectious disease tests also strongly qualify under preventive services. Latent or asymptomatic diseases can progress into severe chronic conditions that challenge healthcare funding and contribute significantly to national healthcare spending. Increasingly sensitive and accurate infectious disease diagnostics are crucial to implementing therapy earlier in the infection and avoiding higher costs of treatment.

Public health officials worldwide have begun to recognize the global nature of infectious diseases - they are no longer a problem of developing countries but touch the very fabric of the social and economic welfare of countries in the industrialized world as well. The globalized world market has exposed far-apart populations to the burdens of infectious disease and exacerbated disease outbreaks. The potential for the re-introduction of eradicated or controlled infectious diseases is higher than ever. Pathogen drug resistance, in particular, is a problem throughout the world and will require a global response.

Table of Contents

Executive Summary

  • A Mix of Traditional and Emerging Testing Technologies
  • Drivers
  • The World Infectious Disease Testing Market
    • Table: Infectious Disease Diagnostic Test Market, 2017-2025 ($ millions)
    • Major Findings of the Report
    • Growth Rates by Type of Testing Product
      • Table: Growth Rate Percentage by Type of Testing Product
  • Companies in the Market
  • Scope and Methodology

Introduction

  • Molecular Testing for Infectious Diseases
    • Immunoassay vs. Molecular
  • Types of Infectious Disease Testing
    • Hepatitis Testing
      • Table: New Cases Hepatitis, U.S.
      • Table: Hepatitis Market Breakout by Product Type Immunoassay, Molecular, Point of Care
  • HHIV Testing
    • Nucleic Acid Tests
      • Table: HIV Testing by Type of Test (POC, Immunoassay, Molecular)
      • Table: Selected EIA HIV Assays
      • Table: Selected Western Blot HIV Assays
      • Table: Selected Indirect Fluorescent Antibody HIV Assays
    • Line Immunoassay
    • Combination Tests
      • Table: Selected Combination HIV Assays
      • Table: Selected Nucleic Acid HIV Assays
      • Table: Selected HIV Assays Used for Screening
    • Sexually Transmitted Diseases
    • TORCH
    • Influenza Rapid and POC Testing
  • Blood Testing
    • Immunoassays
    • Automated Blood Typing and Screening Methods
    • Molecular Methods
    • Reducing Blood Typing Errors
  • POC Infectious Disease Testing
  • Microbiology
    • Chromogenic Media
    • Blood Culture
    • Rapid Micro Tests
  • Sepsis
  • Hospital-Acquired Infections (HAIs)
    • Table: Frequency of the Most Common Nosocomial Infections
    • Table: HAI Costs per Patient Stay
    • Product Examples
    • Products - Cepheid
    • Products - Meridian Biosciences
    • Products - Luminex Corporation
    • Products - Quest Diagnostics
    • Products - Quidel / Life Technologies
    • Products - DiaSorin
    • Hospital-Acquired Pneumonia
      • Table: Significant Approvals for Detecting Serious Healthcare Infections
  • TORCH
  • Trends to Watch
    • Vaccines and Their Impact on Infectious Disease Markets
    • Globalization through Trade and Travel
    • More Walk-In Clinic Testing
    • Skipping the Pathogen: Syndromic Testing
    • IVD Companies Mix and Match
      • Table: Selected Menu Expansion by Partnering and Acquisitions
    • Phage-based Assays
    • Emerging Microbiome Diagnostic Companies
    • New Infectious Disease Threats
    • Sequencing for HIV
    • Greater Outside-the-U.S. Focus

World Infectious Disease Market Analysis

  • Global Markets for Infectious Disease Diagnostics
    • Table: Global Blood Screening Market (Immunoassay, NAT), 2017-2025
    • Table: Global Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
    • Table: Global Malaria and Dengue Diagnostic Market, 2017-2025
    • Table: Global HIV, Labs and POC Market, 2017-2025
    • Table: Global Hepatitis Testing (Lab-Based, POC), 2017-2025
    • Table: Global STDs and HPV Market, 2017-2025
    • Table: Global TORCH Market, 2017-2025
    • Table: Global TB, Labs and POC, 2017-2025
    • Table: Global ID/AST Market (Auto, Manual) 2017-2025
    • Table: Global Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
    • Table: Global Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
    • Table: Global Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC, Other), 2017-2025
  • Global Markets for Infectious Disease Markets by Country
    • United States
      • Table: U.S. Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
      • Table: U.S. Respiratory Disease Market (Flu, Strep A, RSV) 2017-2025
      • Table: U.S. Malaria and Dengue Diagnostic Market, 2017-2025
      • Table: U.S. HIV, Labs and POC Market, 2017-2025
      • Table: U.S. Hepatitis Testing (Lab-Based, POC), 2017-2025
      • Table: U.S. STDs and HPV Market, 2017-2025
      • Table: U.S. TORCH Market, 2017-2025
      • Table: Tuberculosis Testing Market, 2017-2025
      • Table: U.S. ID/AST Market (Auto, Manual) 2017-2025
      • Table: U.S. Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
      • Table: U.S. Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff,VRE, Other HAI), 2017-2025
      • Table: U.S. Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC, Other), 2017-2025
    • Canada
      • Table: Canada Blood Screening Market (Immunoassay, NAT), 2017-2025
      • Table: Canada Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
      • Table: Canada Malaria and Dengue Diagnostic Market, 2017-2025
      • Table: Canada HIV, Labs and POC Market, 2017-2025
      • Table: Canada Hepatitis Testing (Lab-Based, POC), 2017-2025
      • Table: Canada STDs and HPV Market, 2017-2025
      • Table: Canada TORCH Market, 2017-2025
      • Table: Canada TB, Labs and POC, 2017-2025
      • Table: Canada ID/AST Market (Auto, Manual) 2017-2025
      • Table: Canada Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
      • Table: Canada Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
      • Table: Canada Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC, Other), 2017-2025
    • Germany
      • Table: Germany Blood Screening Market (Immunoassay, NAT), 2017-2025
      • Table: Germany Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
      • Table: Germany Malaria and Dengue Diagnostic Market, 2017-2025
      • Table: Germany HIV, Labs and POC Market, 2017-2025
      • Table: Germany Hepatitis Testing (Lab-Based, POC), 2017-2025
      • Table: Germany STDs and HPV Market, 2017-2025
      • Table: Germany TORCH Market, 2017-2025
      • Table: Germany TB, Labs and POC, 2017-2025
      • Table: Germany ID/AST Market (Auto, Manual) 2017-2025
      • Table: Germany Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
      • Table: Germany Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
      • Table: Germany Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC, Other), 2017-2025
    • Spain
      • Table: Spain Blood Screening Market (Immunoassay, NAT), 2017-2025
      • Table: Spain Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
      • Table: Spain Malaria and Dengue Diagnostic Market, 2017-2025
      • Table: Spain HIV, Labs and POC Market, 2017-2025
      • Table: Spain Hepatitis Testing (Lab-Based, POC), 2017-2025
      • Table: Spain STDs and HPV Market, 2017-2025
      • Table: Spain TORCH Market, 2017-2025
      • Table: Spain TB, Labs and POC, 2017-2025
      • Table: Spain ID/AST Market (Auto, Manual) 2017-2025
      • Table: Spain Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
      • Table: Spain Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
      • Table: Spain Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC, Other), 2017-2025
    • France
      • Table: France Blood Screening Market (Immunoassay, NAT), 2017-2025
      • Table: France Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
      • Table: France Malaria and Dengue Diagnostic Market, 2017-2025
      • Table: France HIV, Labs and POC Market, 2017-2025
      • Table: France Hepatitis Testing (Lab-Based, POC), 2017-2025
      • Table: France STDs and HPV Market, 2017-2025
      • Table: France TORCH Market, 2017-2025
      • Table: France TB, Labs and POC, 2017-2025
      • Table: France ID/AST Market (Auto, Manual) 2017-2025
      • Table: France Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
      • Table: France Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
      • Table: France Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC, Other), 2017-2025
    • Italy
      • Table: Italy Blood Screening Market (Immunoassay, NAT), 2017-2025
      • Table: Italy Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
      • Table: Italy Malaria and Dengue Diagnostic Market, 2017-2025
      • Table: Italy HIV, Labs and POC Market, 2017-2025
      • Table: Italy Hepatitis Testing (Lab-Based, POC), 2017-2025
      • Table: Italy STDs and HPV Market, 2017-2025
      • Table: Italy TORCH Market, 2017-2025
      • Table: Italy TB, Labs and POC, 2017-2025
      • Table: Italy ID/AST Market (Auto, Manual) 2017-2025
      • Table: Italy Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
      • Table: Italy Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
      • Table: Italy Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC, Other), 2017-2025
    • U.K.
      • Table: U.K. Blood Screening Market (Immunoassay, NAT), 2017-2025
      • Table: U.K. Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
      • Table: U.K. Malaria and Dengue Diagnostic Market, 2017-2025
      • Table: U.K. HIV, Labs and POC Market, 2017-2025
      • Table: U.K. Hepatitis Testing (Lab-Based, POC), 2017-2025
      • Table: U.K. STDs and HPV Market, 2017-2025
      • Table: U.K. TORCH Market, 2017-2025
      • Table: U.K. TB, Labs and POC, 2017-2025
      • Table: U.K. ID/AST Market (Auto, Manual) 2017-2025
      • Table: U.K. Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
      • Table: U.K. Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
      • Table: U.K. Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC, Other), 2017-2025
    • Other EU
      • Table: Other EU Blood Screening Market (Immunoassay, NAT), 2017-2025
      • Table: Other EU Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
      • Table: Other EU Malaria and Dengue Diagnostic Market, 2017-2025
      • Table: Other EU HIV, Labs and POC Market, 2017-2025
      • Table: Other EU Hepatitis Testing (Lab-Based, POC), 2017-2025
      • Table: Other EU STDs and HPV Market, 2017-2025
      • Table: Other EU TORCH Market, 2017-2025
      • Table: Other EU TB, Labs and POC, 2017-2025
      • Table: Other EU ID/AST Market (Auto, Manual) 2017-2025
      • Table: Other EU Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
      • Table: Other EU Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
      • Table: Other EU Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC, Other), 2017-2025
    • Eastern Europe
      • Table: Eastern Europe Blood Screening Market (Immunoassay, NAT), 2017-2025
      • Table: Eastern Europe Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
      • Table: Eastern Europe Malaria and Dengue Diagnostic Market, 2017-2025
      • Table: Eastern Europe HIV, Labs and POC Market, 2017-2025
      • Table: Eastern Europe Hepatitis Testing (Lab-Based, POC), 2017-2025
      • Table: Eastern Europe STDs and HPV Market, 2017-2025
      • Table: Eastern Europe TORCH Market, 2017-2025
      • Table: Eastern Europe TB, Labs and POC, 2017-2025
      • Table: Eastern Europe ID/AST Market (Auto, Manual) 2017-2025
      • Table: Eastern Europe Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
      • Table: Eastern Europe Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
      • Table: Eastern Europe Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC, Other), 2017-2025
    • Japan
      • Table: Japan Blood Screening Market (Immunoassay, NAT), 2017-2025
      • Table: Japan Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
      • Table: Japan Malaria and Dengue Diagnostic Market, 2017-2025
      • Table: Japan HIV, Labs and POC Market, 2017-2025
      • Table: Japan Hepatitis Testing (Lab-Based, POC), 2017-2025
      • Table: Japan STDs and HPV Market, 2017-2025
      • Table: Japan TORCH Market, 2017-2025
      • Table: Japan TB, Labs and POC, 2017-2025
      • Table: Japan ID/AST Market (Auto, Manual) 2017-2025
      • Table: Japan Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
      • Table: Japan Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
      • Table: Japan Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC, Other), 2017-2025
    • Australia
      • Table: Australia Blood Screening Market (Immunoassay, NAT), 2017-2025
      • Table: Australia Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
      • Table: Australia Malaria and Dengue Diagnostic Market, 2017-2025
      • Table: Australia HIV, Labs and POC Market, 2017-2025
      • Table: Australia Hepatitis Testing (Lab-Based, POC), 2017-2025
      • Table: Australia STDs and HPV Market, 2017-2025
      • Table: Australia TORCH Market, 2017-2025
      • Table: Australia TB, Labs and POC, 2017-2025
      • Table: Australia ID/AST Market (Auto, Manual) 2017-2025
      • Table: Australia Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
      • Table: Australia Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
      • Table: Australia Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC, Other), 2017-2025
    • Singapore
      • Table: Singapore Blood Screening Market (Immunoassay, NAT), 2017-2025
      • Table: Singapore Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
      • Table: Singapore Malaria and Dengue Diagnostic Market, 2017-2025
      • Table: Singapore HIV, Labs and POC Market, 2017-2025
      • Table: Singapore Hepatitis Testing (Lab-Based, POC), 2017-2025
      • Table: Singapore STDs and HPV Market, 2017-2025
      • Table: Singapore TORCH Market, 2017-2025
      • Table: Singapore TB, Labs and POC, 2017-2025
      • Table: Singapore ID/AST Market (Auto, Manual) 2017-2025
      • Table: Singapore Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
      • Table: Singapore Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
      • Table: Singapore Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC, Other), 2017-2025
    • China
      • Table: China Blood Screening Market (Immunoassay, NAT), 2017-2025
      • Table: China Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
      • Table: China Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
      • Table: China HIV, Labs and POC Market, 2017-2025
      • Table: China Hepatitis Testing (Lab-Based, POC), 2017-2025
      • Table: China STDs and HPV Market, 2017-2025
      • Table: China TORCH Market, 2017-2025
      • Table: China TB, Labs and POC, 2017-2025
      • Table: China ID/AST Market (Auto, Manual) 2017-2025
      • Table: China Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
      • Table: China Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
      • Table: China Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC, Other), 2017-2025
    • Malaysia
      • Table: Malaysia Blood Screening Market (Immunoassay, NAT), 2017-2025
      • Table: Malaysia Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
      • Table: Malaysia Malaria and Dengue Diagnostic Market, 2017-2025
      • Table: Malaysia HIV, Labs and POC Market, 2017-2025
      • Table: Malaysia Hepatitis Testing (Lab-Based, POC), 2017-2025
      • Table: Malaysia STDs and HPV Market, 2017-2025
      • Table: Malaysia TORCH Market, 2017-2025
      • Table: Malaysia TB, Labs and POC, 2017-2025
      • Table: Malaysia ID/AST Market (Auto, Manual) 2017-2025
      • Table: Malaysia Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
      • Table: Malaysia Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
      • Table: Malaysia Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC, Other), 2017-2025
    • Turkey
      • Table: Turkey Blood Screening Market (Immunoassay, NAT), 2017-2025
      • Table: Turkey Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
      • Table: Turkey Malaria and Dengue Diagnostic Market, 2017-2025
      • Table: Turkey HIV, Labs and POC Market, 2017-2025
      • Table: Turkey Hepatitis Testing (Lab-Based, POC), 2017-2025
      • Table: Turkey STDs and HPV Market, 2017-2025
      • Table: Turkey TORCH Market, 2017-2025
      • Table: Turkey TB, Labs and POC, 2017-2025
      • Table: Turkey ID/AST Market (Auto, Manual) 2017-2025
      • Table: Turkey Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
      • Table: Turkey Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff,VRE, Other HAI), 2017-2025
      • Table: Turkey Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC, Other), 2017-2025
    • Saudi Arabia
      • Table: Saudi Arabia Blood Screening Market (Immunoassay, NAT), 2017-2025
      • Table: Saudi Arabia Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
      • Table: Saudi Arabia Malaria and Dengue Diagnostic Market, 2017-2025
      • Table: Saudi Arabia HIV, Labs and POC Market, 2017-2025
      • Table: Saudi Arabia Hepatitis Testing (Lab-Based, POC), 2017-2025
      • Table: Saudi Arabia STDs and HPV Market, 2017-2025
      • Table: Saudi Arabia TORCH Market, 2017-2025
      • Table: Saudi Arabia TB, Labs and POC, 2017-2025
      • Table: Saudi Arabia ID/AST Market (Auto, Manual) 2017-2025
      • Table: Saudi Arabia Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
      • Table: Saudi Arabia Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
      • Table: Saudi Arabia Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC, Other), 2017-2025
    • South Africa
      • Table: South Africa Blood Screening Market (Immunoassay, NAT), 2017-2025
      • Table: South Africa Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
      • Table: South Africa Malaria and Dengue Diagnostic Market, 2017-2025
      • Table: South Africa HIV, Labs and POC Market, 2017-2025
      • Table: South Africa Hepatitis Testing (Lab-Based, POC), 2017-2025
      • Table: South Africa STDs and HPV Market, 2017-2025
      • Table: South Africa TORCH Market, 2017-2025
      • Table: South Africa TB, Labs and POC, 2017-2025
      • Table: South Africa ID/AST Market (Auto, Manual) 2017-2025
      • Table: South Africa Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
      • Table: South Africa Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
      • Table: South Africa Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC, Other), 2017-2025
    • Russia
      • Table: Russia Blood Screening Market (Immunoassay, NAT), 2017-2025
      • Table: Russia Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
      • Table: Russia Malaria and Dengue Diagnostic Market, 2017-2025
      • Table: Russia HIV, Labs and POC Market, 2017-2025
      • Table: Russia Hepatitis Testing (Lab-Based, POC), 2017-2025
      • Table: Russia STDs and HPV Market, 2017-2025
      • Table: Russia TORCH Market, 2017-2025
      • Table: Russia TB, Labs and POC, 2017-2025
      • Table: Russia ID/AST Market (Auto, Manual) 2017-2025
      • Table: Russia Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
      • Table: Russia Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff,VRE, Other HAI), 2017-2025
      • Table: Russia Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC, Other), 2017-2025
    • India
      • Table: India Blood Screening Market (Immunoassay, NAT), 2017-2025
      • Table: India Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
      • Table: India Malaria and Dengue Diagnostic Market, 2017-2025
      • Table: India HIV, Labs and POC Market, 2017-2025
      • Table: India Hepatitis Testing (Lab-Based, POC), 2017-2025
      • Table: India STDs and HPV Market, 2017-2025
      • Table: India TORCH Market, 2017-2025
      • Table: India TB, Labs and POC, 2017-2025
      • Table: India ID/AST Market (Auto, Manual) 2017-2025
      • Table: India Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
      • Table: India Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
      • Table: India Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC, Other), 2017-2025
    • Indonesia
      • Table: Indonesia Blood Screening Market (Immunoassay, NAT), 2017-2025
      • Table: Indonesia Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
      • Table: Indonesia Malaria and Dengue Diagnostic Market, 2017-2025
      • Table: Indonesia HIV, Labs and POC Market, 2017-2025
      • Table: Indonesia Hepatitis Testing (Lab-Based, POC), 2017-2025
      • Table: Indonesia STDs and HPV Market, 2017-2025
      • Table: Indonesia TORCH Market, 2017-2025
      • Table: Indonesia TB, Labs and POC, 2017-2025
      • Table: Indonesia ID/AST Market (Auto, Manual) 2017-2025
      • Table: Indonesia Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
      • Table: Indonesia Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
      • Table: Indonesia Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC, Other), 2017-2025
    • Brazil
      • Table: Brazil Blood Screening Market (Immunoassay, NAT), 2017-2025
      • Table: Brazil Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
      • Table: Brazil Malaria and Dengue Diagnostic Market, 2017-2025
      • Table: Brazil HIV, Labs and POC Market, 2017-2025
      • Table: Brazil Hepatitis Testing (Lab-Based, POC), 2017-2025
      • Table: Brazil STDs and HPV Market, 2017-2025
      • Table: Brazil TORCH Market, 2017-2025
      • Table: Brazil TB, Labs and POC, 2017-2025
      • Table: Brazil ID/AST Market (Auto, Manual) 2017-2025
      • Table: Brazil Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
      • Table: Brazil Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
      • Table: Brazil Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC, Other), 2017-2025
    • Taiwan
      • Table: Taiwan Blood Screening Market (Immunoassay, NAT), 2017-2025
      • Table: Taiwan Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
      • Table: Taiwan Malaria and Dengue Diagnostic Market, 2017-2025
      • Table: Taiwan HIV, Labs and POC Market, 2017-2025
      • Table: Taiwan Hepatitis Testing (Lab-Based, POC), 2017-2025
      • Table: Taiwan STDs and HPV Market, 2017-2025
      • Table: Taiwan TORCH Market, 2017-2025
      • Table: Taiwan TB, Labs and POC, 2017-2025
      • Table: Taiwan ID/AST Market (Auto, Manual) 2017-2025
      • Table: Taiwan Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
      • Table: Taiwan Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff,VRE, Other HAI), 2017-2025
      • Table: Taiwan Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC, Other), 2017-2025
    • South Korea
      • Table: South Korea Blood Screening Market (Immunoassay, NAT), 2017-2025
      • Table: South Korea Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
      • Table: South Korea Malaria and Dengue Diagnostic Market, 2017-2025
      • Table: South Korea HIV, Labs and POC Market, 2017-2025
      • Table: South Korea Hepatitis Testing (Lab-Based, POC), 2017-2025
      • Table: South Korea STDs and HPV Market, 2017-2025
      • Table: South Korea TORCH Market, 2017-2025
      • Table: South Korea TB, Labs and POC, 2017-2025
      • Table: South Korea ID/AST Market (Auto, Manual), 2017-2025
      • Table: South Korea Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
      • Table: South Korea Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
      • Table: South Korea Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC, Other), 2017-2025
    • Mexico
      • Table: Mexico Blood Screening Market (Immunoassay, NAT), 2017-2025
      • Table: Mexico Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
      • Table: Mexico Malaria and Dengue Diagnostic Market, 2017-2025
      • Table: Mexico HIV, Labs and POC Market, 2017-2025
      • Table: Mexico Hepatitis Testing (Lab-Based, POC), 2017-2025
      • Table: Mexico STDs and HPV Market, 2017-2025
      • Table: Mexico TORCH Market, 2017-2025
      • Table: Mexico TB, Labs and POC, 2017-2025
      • Table: Mexico ID/AST Market (Auto, Manual), 2017-2025
      • Table: Mexico Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
      • Table: Mexico Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
      • Table: Mexico Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC, Other), 2017-2025
    • Chile
      • Table: Chile Blood Screening Market (Immunoassay, NAT), 2017-2025
      • Table: Chile Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
      • Table: Chile Malaria and Dengue Diagnostic Market, 2017-2025
      • Table: Chile HIV, Labs and POC Market, 2017-2025
      • Table: Chile Hepatitis Testing (Lab-Based, POC), 2017-2025
      • Table: Chile STDs and HPV Market, 2017-2025
      • Table: Chile TORCH Market, 2017-2025
      • Table: Chile TB, Labs and POC, 2017-2025
      • Table: Chile ID/AST Market (Auto, Manual), 2017-2025
      • Table: Chile Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
      • Table: Chile Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
      • Table: Chile Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging infectious Disease Tests, Home OTC, Other), 2017-2025
    • Columbia
      • Table: Columbia Blood Screening Market (Immunoassay, NAT), 2017-2025
      • Table: Columbia Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
      • Table: Columbia Malaria and Dengue Diagnostic Market, 2017-2025
      • Table: Columbia HIV, Labs and POC Market, 2017-2025
      • Table: Columbia Hepatitis Testing (Lab-Based, POC), 2017-2025
      • Table: Columbia STDs and HPV Market, 2017-2025
      • Table: Columbia TORCH Market, 2017-2025
      • Table: Columbia TB, Labs and POC, 2017-2025
      • Table: Columbia ID/AST Market (Auto, Manual) 2017-2025
      • Table: Columbia Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
      • Table: Columbia Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
      • Table: Columbia Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC, Other), 2017-2025
    • Other LATAM
      • Table: Other LATAM Blood Screening Market (Immunoassay, NAT), 2017-2025
      • Table: Other LATAM Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
      • Table: Other LATAM Malaria and Dengue Diagnostic Market, 2017-2025
      • Table: Other LATAM HIV, Labs and POC Market, 2017-2025
      • Table: Other LATAM Hepatitis Testing (Lab-Based, POC), 2017-2025
      • Table: Other LATAM STDs and HPV Market, 2017-2025
      • Table: Other LATAM TORCH Market, 2017-2025
      • Table: Other LATAM TB, Labs and POC, 2017-2025
      • Table: Other LATAM ID/AST Market (Auto, Manual) 2017-2025
      • Table: Other LATAM Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
      • Table: Other LATAM Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
      • Table: Other LATAM Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC, Other), 2017-2025
    • Rest of World
      • Table: ROW Blood Screening Market (Immunoassay, NAT), 2017-2025
      • Table: ROW Respiratory Diagnostics Market (Influenza Tests, Strep A, RSV), 2017-2025
      • Table: ROW Malaria and Dengue Diagnostic Market, 2017-2025
      • Table: ROW HIV, Labs and POC Market, 2017-2025
      • Table: ROW Hepatitis Testing (Lab-Based, POC), 2017-2025
      • Table: ROW STDs and HPV Market, 2017-2025
      • Table: ROW TORCH Market, 2017-2025
      • Table: ROW TB, Labs and POC, 2017-2025
      • Table: ROW ID/AST Market (Auto, Manual) 2017-2025
      • Table: ROW Other Microbiology Market (Blood Culture, Chromogenic Media, Rapid Micro), 2017-2025
      • Table: ROW Bloodstream and Hospital-Acquired Infection Testing Market (Sepsis, MRSA, C. diff, VRE, Other HAI), 2017-2025
      • Table: ROW Other Infectious Disease Diagnostic Markets (Parasitology, Mycology, Emerging Infectious Disease Tests, Home OTC, Other), 2017-2025

Companies in the Market

  • Abbott Diagnostics
    • Table: Abbott Recent Revenue History, 2013-2017 ($ million)
    • Table: Abbott's Revenue in Selected Test Segments, 2013-2017 ($ million) (Histology (Vysis), Chem/Immuno, Hematology, Molecular, Point of Care, Diabetes)
    • Alere Acquisition Update
    • Core Lab
    • Coagulation
    • Infectious Diseases - Molecular
    • HIV
    • Alere Reader
    • Zika
  • Beckman Coulter, Inc. / Danaher
    • Table: Beckman Coulter, Inc. / Danaher Recent Revenue History, 2011-2017 ($ million, estimated)
    • Table: Beckman Coulter's Revenue in Selected Test Segments ($ million, estimated), 2011-2016 (Routine Chemistry, Immunoassays, Hematology, Microbiology)
    • Immunoassays
  • Becton, Dickinson and Company (BD)
    • Table: Becton, Dickinson and Company (BD) Recent Revenue History, 2013-2017 (diagnostic systems, $ million)
    • Table: BD's Revenue in Selected IVD Test Segments ($ million, estimated), 2013 (Molecular, Microbiology ID/AST, Microbiology media, Rapid Tests, Blood Culture)
    • BD Max Molecular
    • ID/AST
    • POC Veritor
  • bioMérieux Inc.
    • Table: bioMérieux Recent Revenue History, 2013-2017 (Total IVDs, $ million)
    • Table: bioMérieux's Revenue in Selected IVD Test Segments ($ million), 2013-2017 (Microbiology, Immunoassays, Molecular, FilmArray)
    • Traditional Microbiology
    • Blood Culture
    • Immunoassays
    • Mass Spectrometry
    • BioFire Diagnostics Business
  • Bio-Rad Laboratories, Inc.
    • Table: Bio-Rad Laboratories Recent Revenue History, 2013-2017 (all diagnostics, $ million, estimated)
    • Table: Bio-Rad's Revenue in Selected Product Segments ($ million, estimated), 2012-2016 (Quality Control, Immunoassays, Microbiology (all), Blood Bank)
    • Quality Control
    • Blood Bank
    • Infectious Diseases - Molecular
    • Immunoassays
    • Droplet Digital PCR
    • Sequencing
  • Cepheid / Danaher
    • Table: Cepheid Recent Revenue History, 2013-2017 (clinical product sales, $ million)
    • Tuberculosis
    • Microbiology
    • Influenza
    • POC HIV
  • Danaher Corporation
    • Table: Danaher Corp. Recent Revenue History, 2014-2017 ($ million - diagnostics - most recent years for which data is available, estimated)
    • Table: Danaher's Revenue in Selected Business Segments, 2013-2017 ($ million, estimated)
    • For 2016 vs 2015, Danaher Reported . . .
    • Beckman Coulter
    • Radiometer
    • Leica Biosystems
    • Cepheid
    • Radiometer A/S Profile
      • Table: Radiometer Recent Revenue History, 2012-2016 (estimated, core products, $ million)
    • Radiometer, POC
    • Radiometer, Critical Care
    • Radiometer, Immunoassays
  • Grifols
    • Recent Revenue History
      • Table: Grifols Diagnostic Product Revenues, 2012-2017 ($ million, estimated) (Core, Blood Screen, Total)
    • 2016 Summary as Reported by Grifols
    • Blood Transfusion Business
    • Blood Bank CLIA Lab
    • Coagulation
    • Acquisitions and Collaborations
  • Hologic, Inc.
    • Table: Hologic Recent Revenue History, 2013-2017 (total Dx; $ million)
    • Table: Hologic's Revenue in Selected Segments ($ million), 2013-2017 (HPV (legacy),
    • Panther Molecular System
    • Panther Fusion
    • Blood Bank - Zika Virus
  • InSilixa, Inc
    • Table: InSilixa Corporate Summary
    • Company Overview
    • Products
  • Meridian BioScience, Inc
    • Table: Meridian BioScience Corporate Summary
    • Company Overview
    • Products
    • Performance Review
      • Table: Meridian Bioscience (2014-2017) ($ millions)
  • Ortho Clinical Diagnostics
    • Table: Ortho Clinical Diagnostics Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table: Ortho Clinical Diagnostics Revenue (2014-2017) ($ millions)
  • PerkinElmer, Inc. (PE)
    • Table: PerkinElmer Recent Revenue History, 2014-2017 ($ million, estimated)
    • Sequencing
    • Lab Services
    • Expansion
  • QIAGEN N.V.
    • Table: QIAGEN Recent Revenue History, 2013-2017 ($ million)
    • Table: QIAGEN Molecular IVD Product Revenues ($ million), 2013-2017 (HPV, TB, Other Molecular,Total IVD)
    • Tuberculosis
  • Quidel Corporation
    • Table: Quidel Recent Revenue History, 2013-2016 ($ million)
    • Immunoassays
    • The Solana Business
  • Roche Diagnostics
    • Table: Roche Diagnostics Recent Revenue History, 2011-2017 ($ millions)
    • Table: Roche's Revenue in Selected Test Segments, 2013-2016 ($ millions, estimated) (Chemistry/Immuno, Diabetes, Molecular, Histology)
    • Immunoassays
    • Global Access Program for HIV
    • cobas Liat System - POC
    • HPV
    • Blood Bank
  • Siemens Healthineers
    • Table: Siemens Recent Revenue History, 2012-2015 (total IVD; $ million)
    • Table: Siemens' IVD Product Sales in Selected Test Segments, 2012-2015 ($ million) (Chemistry/Immunoassays, Coagulation, Hematology, Molecular, Urinalysis, Blood Gases)
    • Immunoassays
  • Thermo Fisher Scientific Inc.
    • Table: Thermo Fisher Recent Revenue History, 2013-2016 (clinical diagnostics, $ million)
    • Table: Thermo Fisher Product Sales in Selected Test Segments, 2015-2016 ($ million) (Clinical products, Immunoassays, Microbiology, Histology)
    • Microbiology
    • Molecular Test Business
    • Mass Spectrometry
  • Trinity Biotech PLC
    • Table: Trinity Biotech Corporate Summary
    • Company Overview
    • Products
    • Company Financials
      • Table: Trinity Biotech Revenue (2014-2017) ($ thousands)
  • WAMA Diagnostica
    • Table: WAMA Diagnostica Corporate Summary
    • Company Overview
    • Products
  • Wave 80 Biosciences
    • Table: Wave 80 Biosciences Corporate Summary
    • Company Overview
    • Products
  • Xagenic
    • Table: Xagenic Corporate Summary
    • Company Overview
    • Products
Back to Top